Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 426–450 of 566 matching trials (filtered from 7,816) · page 18 of 23, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Activity Tracking, Care Partner Co-participation, Text Reminders, Instructional Education, Video-Guided Physical Rehabilitation, and Exercise NCT07321587 ACTIVE Intervention Runs in: United States · 1 site |
NA other |
RECRUITING | 100 | NYU Langone Health OTHER |
2026-01-28 |
|
Epileptic Hippocampus in Alzheimer's Disease NCT05899764 Brivaracetam Runs in: United States · 1 site |
PHASE1|PHASE2 other |
NOT_YET_RECRUITING | 25 | University of California, Los Angeles OTHER |
2026-01-27 |
|
A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK NCT06372821 NIO752; Placebo Runs in: United Kingdom; United States · 2 sites |
PHASE1 other |
RECRUITING | 10 | University College, London OTHER |
2026-01-27 |
|
Biomarker Exploration in Aging, Cognition and Neurodegeneration NCT03860857 Amyloid PET scan; Tau PET scan using MK-6240; Neurocognitive testing; MRI Runs in: United States · 1 site |
PHASE3 other |
RECRUITING | 300 | University of California, Irvine OTHER |
2026-01-23 |
|
UPenn Observational Research Repository on Neurodegenerative Disease NCT04715399 No intervention Runs in: United States · 1 site |
NA other |
RECRUITING | 1,000 | University of Pennsylvania OTHER |
2026-01-22 |
|
Home Based Functional Balance Intervention for Multiple Sclerosis NCT07355387 Multicomponent balance intervention consisting of four components i... Runs in: United States · 1 site |
NA other |
RECRUITING | 75 | University of Illinois at Chicago OTHER |
2026-01-21 |
|
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study NCT05677880 Study Procedures Runs in: United States · 12 sites |
NA other |
RECRUITING | 660 | University of Wisconsin, Madison OTHER |
2026-01-15 |
|
Bumetanide in Patients With Alzheimer's Disease NCT06052163 Bumetanide; Placebo Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 40 | Stanford University OTHER |
2026-01-14 |
|
Vestibular Therapy in Alzheimer's Disease NCT03799991 Vestibular physical therapy; Active control Runs in: United States · 1 site |
NA other |
RECRUITING | 100 | Johns Hopkins University OTHER |
2026-01-12 |
|
Non-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia NCT05661084 Transcranial alternating current stimulation (tACS) (active); Trans... Runs in: United States · 1 site |
NA other |
RECRUITING | 144 | Hebrew SeniorLife OTHER |
2026-01-12 |
|
Caregiver as Navigator: Develop Skills Online (CAN-DO) NCT06177990 Caregiver as Navigator: Develop Skills Online (CAN-DO) program; Hea... Runs in: United States · 1 site |
NA other |
RECRUITING | 270 | Emory University OTHER |
2026-01-12 |
|
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease NCT03671889 Blood Brain Barrier (BBB) Disruption Runs in: United States · 10 sites |
NA other |
RECRUITING | 50 | InSightec INDUSTRY |
2026-01-09 |
|
Inhibition of Aggressive Behavior in Participants With Fragile X Syndrome NCT07328529 SRX246; Placebo Runs in: United States · 3 sites |
PHASE2 other |
NOT_YET_RECRUITING | 80 | Azevan Pharmaceuticals INDUSTRY |
2026-01-09 |
|
Amyotrophic Lateral Sclerosis (ALS) Families Project NCT03865420 Runs in: United States · 1 site |
NA other |
RECRUITING | 300 | Columbia University OTHER |
2026-01-07 |
|
Innate Immunity Stimulation Via TLR9 in Early AD NCT05606341 CpG1018; CpG1018; CpG1018; Placebo Runs in: United States · 1 site |
PHASE1 other |
RECRUITING | 18 | NYU Langone Health OTHER |
2026-01-07 |
|
Daridorexant to Prevent Post-cardiotomy Delirium NCT07217912 Daridorexant 50 mg; Placebo Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 80 | University of Rochester OTHER |
2026-01-07 |
|
A Trial to Test Intermittent Deep Brain Stimulation of Nucleus Basalis of Meynert to Treat Alzheimers. NCT07218081 Intermittent deep brain stimulation of the nucleus basalis of Meynert Runs in: United States · 1 site |
PHASE1 other |
RECRUITING | 12 | Augusta University OTHER |
2026-01-07 |
|
MR Evaluation of Cerebrospinal Fluid (CSF) Dynamics NCT04099823 MRI screening form; Urine pregnancy test; MR brain Runs in: United States · 1 site |
NA other |
RECRUITING | 50 | Mayo Clinic OTHER |
2026-01-06 |
|
Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer's Disease and Other Dementias 2.0 NCT05950607 TRAIN AD 2.0 Runs in: United States · 1 site |
NA other |
RECRUITING | 750 | Hebrew SeniorLife OTHER |
2026-01-06 |
|
Multi-Modal Digital Monitoring of Disease Symptoms Huntington's Disease NCT07315984 Runs in: United States · 2 sites |
NA other |
NOT_YET_RECRUITING | 75 | BioSensics INDUSTRY |
2026-01-05 |
|
Remote tDCS and Chair Yoga for Chronic Knee Pain in Alzheimer's Patients NCT07303998 Active tDCS paired with active online chair yoga Runs in: United States · 1 site |
NA other |
RECRUITING | 40 | University of Arizona OTHER |
2025-12-26 |
|
PET Imaging Evaluation of [11C]SY08 NCT06098612 C11-SY08 Runs in: United States · 1 site |
EARLY_PHASE1 other |
RECRUITING | 40 | Massachusetts General Hospital OTHER |
2025-12-24 |
|
Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A NCT06932809 18F-JSS20-183A PET; Brain MRI; Amyloid PET; Neurological Assessments Runs in: United States · 2 sites |
EARLY_PHASE1 other |
RECRUITING | 90 | University of Pennsylvania OTHER |
2025-12-23 |
|
GAMES Intervention in MCI (Mild Cognitive Impairment) NCT07296133 Online Gameplay Intervention; Waitlist control Runs in: United States · 1 site |
NA other |
RECRUITING | 124 | Emory University OTHER |
2025-12-22 |
|
A Study of Dual-task Exercise Training to Prevent Falls Among Older Adults With Mild Cognitive Impairment NCT05725668 dual-task tai ji quan; standard tai ji quan; stretching Runs in: United States · 1 site |
NA other |
RECRUITING | 336 | Oregon Research Institute OTHER |
2025-12-17 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
Last updated
From the research library
The highest-scoring studies we hold on this subject, each summarized in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial